Report Detail
Global Perfluorodecalin for Ophthalmic Surgery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4710150 |
- 17 June, 2026 |
- Global |
- 95 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Perfluorodecalin for Ophthalmic Surgery market size was valued at US$ 40.03 million in 2025 and is forecast to a readjusted size of US$ 58.25 million by 2032 with a CAGR of 5.6% during review period.
In 2025, global Perfluorodecalin for Ophthalmic Surgery production reached approximately 270 k units, with an average global market price of around US$144 per unit. Perfluorodecalin for ophthalmic surgery is a perfluorocarbon aromatic organic compound. At room temperature, it is a colorless, odorless, non-toxic liquid with a low boiling point and a high boiling point. It can be used to fix and protect the eyeball during ophthalmic surgery.
According to the 2022 White Paper on Chronic Disease Management of Common Ocular Fundus Diseases in China issued by the National Clinical Research Center for Ocular Diseases, the prevalence of fundus diseases reaches 21.4% among those aged 60 and above and rises to 25.6% among those over 70. The rising caseload of rhegmatogenous retinal detachment requiring vitrectomy sustains stable clinical usage of perfluorodecalin as a temporary intraoperative tamponade agent. Perfluorodecalin represents the longest-established product within the ophthalmic heavy liquid category, with product standards already filed with and approved by the NMPA. However, as a first-generation perfluorocarbon liquid, its clinical limitations center on postoperative residual concerns tied to purity. Comparative studies of different commercial brands have detected significant variability in hydrogenated impurity levels across batches, with 1H-PFO concentrations ranging from below 1 ppm to 376 ppm, directly affecting postoperative inflammatory risk control. Breakthroughs in purification technology are becoming the critical threshold for maintaining competitiveness in the high-end segment. From a regulatory standpoint, perfluorodecalin is classified as a Class III high-risk medical device across major markets, subject to rigorous premarket approval. China‘s NMPA mandates purity of no less than 95% as a fundamental registration criterion. The EU REACH restriction proposal on PFAS has placed fluorocarbon compounds including perfluorodecalin under review, progressively raising compliance costs. In China, provincial volume-based procurement initiatives have included ophthalmic heavy liquids within price linkage mechanisms, typically capping bid prices at national historical lows while preserving hospitals’ discretionary allocation rights beyond contracted volumes. Upstream fluorocarbon raw material production capacity is being scaled domestically, with local manufacturers having already obtained Class III medical device registration certificates for perfluorodecalin, steadily enhancing supply chain autonomy. The market will continue to evolve along two principal trajectories: purification technology upgrades and regional supply-side structural substitution, with higher clinical purity requirements serving as the decisive variable in product differentiation.
This report is a detailed and comprehensive analysis for global Perfluorodecalin for Ophthalmic Surgery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Perfluorodecalin for Ophthalmic Surgery market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorodecalin for Ophthalmic Surgery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorodecalin for Ophthalmic Surgery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perfluorodecalin for Ophthalmic Surgery market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perfluorodecalin for Ophthalmic Surgery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perfluorodecalin for Ophthalmic Surgery market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch + Lomb, BVI Medical, Geuder AG, DORC (ZEISS), Alchimia srl, Pharmpur, Toomac Ophthalmic, Micromed srl, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Perfluorodecalin for Ophthalmic Surgery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity ≥ 95%
Purity ≥ 97%
Market segment by Specification
5 ml/unit
7 ml/unit
Market segment by Package
Sterile Vials
Pre-filled Syringes
Market segment by Application
Hospital
Ophthalmology Clinic
Major players covered
Bausch + Lomb
BVI Medical
Geuder AG
DORC (ZEISS)
Alchimia srl
Pharmpur
Toomac Ophthalmic
Micromed srl
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perfluorodecalin for Ophthalmic Surgery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perfluorodecalin for Ophthalmic Surgery, with price, sales quantity, revenue, and global market share of Perfluorodecalin for Ophthalmic Surgery from 2021 to 2026.
Chapter 3, the Perfluorodecalin for Ophthalmic Surgery competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perfluorodecalin for Ophthalmic Surgery breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Perfluorodecalin for Ophthalmic Surgery market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perfluorodecalin for Ophthalmic Surgery.
Chapter 14 and 15, to describe Perfluorodecalin for Ophthalmic Surgery sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Purity ≥ 95%
- 1.3.3 Purity ≥ 97%
- 1.4 Market Analysis by Specification
- 1.4.1 Overview: Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.4.2 5 ml/unit
- 1.4.3 7 ml/unit
- 1.5 Market Analysis by Package
- 1.5.1 Overview: Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Package: 2021 Versus 2025 Versus 2032
- 1.5.2 Sterile Vials
- 1.5.3 Pre-filled Syringes
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Ophthalmology Clinic
- 1.7 Global Perfluorodecalin for Ophthalmic Surgery Market Size & Forecast
- 1.7.1 Global Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Perfluorodecalin for Ophthalmic Surgery Sales Quantity (2021-2032)
- 1.7.3 Global Perfluorodecalin for Ophthalmic Surgery Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Bausch + Lomb
- 2.1.1 Bausch + Lomb Details
- 2.1.2 Bausch + Lomb Major Business
- 2.1.3 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.1.4 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Bausch + Lomb Recent Developments/Updates
- 2.2 BVI Medical
- 2.2.1 BVI Medical Details
- 2.2.2 BVI Medical Major Business
- 2.2.3 BVI Medical Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.2.4 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 BVI Medical Recent Developments/Updates
- 2.3 Geuder AG
- 2.3.1 Geuder AG Details
- 2.3.2 Geuder AG Major Business
- 2.3.3 Geuder AG Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.3.4 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Geuder AG Recent Developments/Updates
- 2.4 DORC (ZEISS)
- 2.4.1 DORC (ZEISS) Details
- 2.4.2 DORC (ZEISS) Major Business
- 2.4.3 DORC (ZEISS) Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.4.4 DORC (ZEISS) Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 DORC (ZEISS) Recent Developments/Updates
- 2.5 Alchimia srl
- 2.5.1 Alchimia srl Details
- 2.5.2 Alchimia srl Major Business
- 2.5.3 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.5.4 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Alchimia srl Recent Developments/Updates
- 2.6 Pharmpur
- 2.6.1 Pharmpur Details
- 2.6.2 Pharmpur Major Business
- 2.6.3 Pharmpur Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.6.4 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Pharmpur Recent Developments/Updates
- 2.7 Toomac Ophthalmic
- 2.7.1 Toomac Ophthalmic Details
- 2.7.2 Toomac Ophthalmic Major Business
- 2.7.3 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.7.4 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Toomac Ophthalmic Recent Developments/Updates
- 2.8 Micromed srl
- 2.8.1 Micromed srl Details
- 2.8.2 Micromed srl Major Business
- 2.8.3 Micromed srl Perfluorodecalin for Ophthalmic Surgery Product and Services
- 2.8.4 Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Micromed srl Recent Developments/Updates
3 Competitive Environment: Perfluorodecalin for Ophthalmic Surgery by Manufacturer
- 3.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Manufacturer (2021-2026)
- 3.3 Global Perfluorodecalin for Ophthalmic Surgery Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Perfluorodecalin for Ophthalmic Surgery by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Perfluorodecalin for Ophthalmic Surgery Manufacturer Market Share in 2025
- 3.4.3 Top 6 Perfluorodecalin for Ophthalmic Surgery Manufacturer Market Share in 2025
- 3.5 Perfluorodecalin for Ophthalmic Surgery Market: Overall Company Footprint Analysis
- 3.5.1 Perfluorodecalin for Ophthalmic Surgery Market: Region Footprint
- 3.5.2 Perfluorodecalin for Ophthalmic Surgery Market: Company Product Type Footprint
- 3.5.3 Perfluorodecalin for Ophthalmic Surgery Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Perfluorodecalin for Ophthalmic Surgery Market Size by Region
- 4.1.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Region (2021-2032)
- 4.1.2 Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Region (2021-2032)
- 4.1.3 Global Perfluorodecalin for Ophthalmic Surgery Average Price by Region (2021-2032)
- 4.2 North America Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021-2032)
- 4.3 Europe Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021-2032)
- 4.4 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021-2032)
- 4.5 South America Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021-2032)
- 4.6 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 5.2 Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Type (2021-2032)
- 5.3 Global Perfluorodecalin for Ophthalmic Surgery Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 6.2 Global Perfluorodecalin for Ophthalmic Surgery Consumption Value by Application (2021-2032)
- 6.3 Global Perfluorodecalin for Ophthalmic Surgery Average Price by Application (2021-2032)
7 North America
- 7.1 North America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 7.2 North America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 7.3 North America Perfluorodecalin for Ophthalmic Surgery Market Size by Country
- 7.3.1 North America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Country (2021-2032)
- 7.3.2 North America Perfluorodecalin for Ophthalmic Surgery Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 8.2 Europe Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 8.3 Europe Perfluorodecalin for Ophthalmic Surgery Market Size by Country
- 8.3.1 Europe Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Perfluorodecalin for Ophthalmic Surgery Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Market Size by Region
- 9.3.1 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Perfluorodecalin for Ophthalmic Surgery Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 10.2 South America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 10.3 South America Perfluorodecalin for Ophthalmic Surgery Market Size by Country
- 10.3.1 South America Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Country (2021-2032)
- 10.3.2 South America Perfluorodecalin for Ophthalmic Surgery Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Market Size by Country
- 11.3.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Perfluorodecalin for Ophthalmic Surgery Market Drivers
- 12.2 Perfluorodecalin for Ophthalmic Surgery Market Restraints
- 12.3 Perfluorodecalin for Ophthalmic Surgery Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Perfluorodecalin for Ophthalmic Surgery and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Perfluorodecalin for Ophthalmic Surgery
- 13.3 Perfluorodecalin for Ophthalmic Surgery Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Perfluorodecalin for Ophthalmic Surgery Typical Distributors
- 14.3 Perfluorodecalin for Ophthalmic Surgery Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Perfluorodecalin for Ophthalmic Surgery. Industry analysis & Market Report on Perfluorodecalin for Ophthalmic Surgery is a syndicated market report, published as Global Perfluorodecalin for Ophthalmic Surgery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Perfluorodecalin for Ophthalmic Surgery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
